ADC Therapeutics (NYSE:ADCT) Price Target Cut to $5.00 by Analysts at Royal Bank Of Canada
ADC Therapeutics (NYSE:ADCT – Free Report) had its target price trimmed by Royal Bank Of Canada from $8.00 to $5.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock. ADCT has been the topic of a number of other research reports. HC Wainwright reissued a “buy” […]
